China (Mainland)
Premiumsupplier 
Geftinib CAS: 184475-35-2 CAS NO.184475-35-2
- FOB Price: USD: 1.00-2.00 /Metric Ton Get Latest Price
- Min.Order: 5 Metric Ton
- Payment Terms: L/C,T/T
- Available Specifications:
99%(1-5)Metric Ton99%(5-20)Metric Ton
- Product Details
Keywords
- Geftinib
- Iressa
- 184475-35-2
Quick Details
- ProName: Geftinib CAS: 184475-35-2
- CasNo: 184475-35-2
- Molecular Formula: C22H24ClFN4O3
- Appearance: White powder
- Application: Pharmaceutical Intermediates
- DeliveryTime: Within 2 weeks after order confirmatio...
- PackAge: 25kg/drum or 20kg/bag
- Port: Qingdao Port
- ProductionCapacity: 1000 Metric Ton/Year
- Purity: 99%
- Storage: Room Temperature
- Transportation: By sea or by air
- LimitNum: 5 Metric Ton
- CAS: 184475-35-2
- Molecular Formula: C22H24ClFN4O3
Superiority
Product Name: Gefitinib
Synonyms: Gefitinib N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;IRESSA;GEFITINIB;AKOS 91371;n-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine;Gefitinib 184475-35-2;Gefitinib(TINIBS)
CAS No: 184475-35-2
Molecular Formula: C22H24ClFN4O3
Molecular Weight: 446.9
EC No: 643-034-7
Usage: Gefitinib, is a drug used for certain breast, lung , and other cancers, also known as Iressa, a selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, for the treatment of prior locally advanced or metastatic non-chemical treatment
or unsuitable for chemotherapysmall cell lung cancer (NSCLC).
Details
|
Test items |
Specification |
|
Characters |
A white or almost white crystalline powder |
|
Appearance of solution |
Meets the requirements |
|
pH |
3.0-4.5 |
|
Specific optical rotation |
232º~239º |
|
Related substances |
Each of impurities A,B,C,D,E≤0.2% |
|
Any other impurity ≤0.1% |
|
|
Total impurities ≤0.3% |
|
|
Heavy metals |
≤0.002% |
|
Loss on drying |
≤0.5% |
|
Sulphated ash |
≤0.1%
|
|
Assay |
98.5%~101.0% |